| Year |
Citation |
Score |
| 2023 |
Weiner AK, Radaoui AB, Tsang M, Martinez D, Sidoli S, Conkrite KL, Delaidelli A, Modi A, Rokita JL, Patel K, Lane MV, Zhang B, Zhong C, Ennis B, Miller DP, ... ... Raman P, et al. A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma. Biorxiv : the Preprint Server For Biology. PMID 38106022 DOI: 10.1101/2023.12.06.570390 |
0.327 |
|
| 2020 |
Petralia F, Tignor N, Reva B, Koptyra M, Chowdhury S, Rykunov D, Krek A, Ma W, Zhu Y, Ji J, Calinawan A, Whiteaker JR, Colaprico A, Stathias V, Omelchenko T, ... ... Raman P, et al. Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer. Cell. PMID 33242424 DOI: 10.1016/j.cell.2020.10.044 |
0.318 |
|
| 2020 |
Tetri LH, Kolla V, Golden RL, Iyer R, Croucher JL, Choi JH, Macfarland SP, Naraparaju K, Guan P, Nguyen F, Gaonkar KS, Raman P, Brodeur GM. RET receptor expression and interaction with TRK receptors in neuroblastomas. Oncology Reports. PMID 32319659 DOI: 10.3892/Or.2020.7583 |
0.311 |
|
| 2020 |
Yarmarkovich M, Farrel A, Sison A, di Marco M, Raman P, Parris JL, Monos D, Lee H, Stevanovic S, Maris JM. Immunogenicity and Immune Silence in Human Cancer. Frontiers in Immunology. 11: 69. PMID 32256484 DOI: 10.3389/Fimmu.2020.00069 |
0.349 |
|
| 2020 |
Martin CJ, Datta A, Littlefield C, Kalra A, Chapron C, Wawersik S, Dagbay KB, Brueckner CT, Nikiforov A, Danehy FT, Streich FC, Boston C, Simpson A, Jackson JW, Lin S, ... ... Raman P, et al. Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape. Science Translational Medicine. 12. PMID 32213632 DOI: 10.1126/Scitranslmed.Aay8456 |
0.36 |
|
| 2020 |
Sussman RT, Rokita JL, Huang K, Raman P, Rathi KS, Martinez D, Bosse KR, Lane M, Hart LS, Bhatti T, Pawel B, Maris JM. CAMKV Is a Candidate Immunotherapeutic Target in Amplified Neuroblastoma. Frontiers in Oncology. 10: 302. PMID 32211329 DOI: 10.3389/Fonc.2020.00302 |
0.369 |
|
| 2020 |
Nabbi A, Sun P, Sumedha S, Zhu K, Yang SYC, Paulson JN, Kool M, Rathi K, Kalletla K, Raman P, Zhu Y, Resnick AC, Jones DTW, Jäger N, Pfister SM, et al. Abstract PR06: The immunogenomic landscape of pediatric primary solid tumors Cancer Research. 80. DOI: 10.1158/1538-7445.Pedca19-Pr06 |
0.434 |
|
| 2020 |
Petralia F, Tignor N, Reva B, Raman P, Chowdhury S, Rykunov D, Krek A, Ma W, Ji J, Song X, Zhu Y, Rokita JL, Colaprico A, Calinawan A, Whiteaker JR, et al. Abstract 445: Integrated proteogenomic characterization across seven histological types of pediatric brain tumors Cancer Research. 80: 445-445. DOI: 10.1158/1538-7445.Am2020-445 |
0.378 |
|
| 2019 |
Rokita JL, Rathi KS, Cardenas MF, Upton KA, Jayaseelan J, Cross KL, Pfeil J, Egolf LE, Way GP, Farrel A, Kendsersky NM, Patel K, Gaonkar KS, Modi A, Berko ER, ... ... Raman P, et al. Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design. Cell Reports. 29: 1675-1689.e9. PMID 31693904 DOI: 10.1016/J.Celrep.2019.09.071 |
0.427 |
|
| 2019 |
Ijaz H, Koptyra M, Gaonkar KS, Rokita JL, Baubet VP, Tauhid L, Zhu Y, Brown M, Lopez G, Zhang B, Diskin SJ, Vaksman Z, Mason JL, Appert E, Lilly J, ... ... Raman P, et al. Pediatric High Grade Glioma Resources from the Children's Brain Tumor Tissue Consortium (Cbttc). Neuro-Oncology. PMID 31613963 DOI: 10.1093/Neuonc/Noz192 |
0.301 |
|
| 2019 |
Raman P, Zimmerman S, Rathi KS, de Torrenté L, Sarmady M, Wu C, Leipzig J, Taylor DM, Tozeren A, Mar JC. A comparison of survival analysis methods for cancer gene expression RNA-Sequencing data. Cancer Genetics. 235: 1-12. PMID 31296308 DOI: 10.1016/J.Cancergen.2019.04.004 |
0.574 |
|
| 2019 |
Surrey LF, MacFarland SP, Chang F, Cao K, Rathi KS, Akgumus GT, Gallo D, Lin F, Gleason A, Raman P, Aplenc R, Bagatell R, Minturn J, Mosse Y, Santi M, et al. Clinical utility of custom-designed NGS panel testing in pediatric tumors. Genome Medicine. 11: 32. PMID 31133068 DOI: 10.1186/S13073-019-0644-8 |
0.361 |
|
| 2019 |
Taylor DM, Aronow BJ, Tan K, Bernt K, Salomonis N, Greene CS, Frolova A, Henrickson SE, Wells A, Pei L, Jaiswal JK, Whitsett J, Hamilton KE, MacParland SA, Kelsen J, ... ... Raman P, et al. The Pediatric Cell Atlas: Defining the Growth Phase of Human Development at Single-Cell Resolution. Developmental Cell. PMID 30930166 DOI: 10.1016/J.Devcel.2019.03.001 |
0.58 |
|
| 2019 |
Sano R, Krytska K, Larmour CE, Raman P, Martinez D, Ligon GF, Lillquist JS, Cucchi U, Orsini P, Rizzi S, Pawel BR, Alvarado D, Mossé YP. An antibody-drug conjugate directed to the ALK receptor demonstrates efficacy in preclinical models of neuroblastoma. Science Translational Medicine. 11. PMID 30867324 DOI: 10.1126/Scitranslmed.Aau9732 |
0.37 |
|
| 2019 |
Zhu Y, Guo Y, Heath AP, Raman P, Appert E, Mason J, Zhang B, Kalletla K, Brown MA, Singh N, Farrow BK, Killada P, Kim MC, Felmeister A, Koptyra MP, et al. Abstract 3667: The Pediatric Brain Tumor Atlas - Transforming the landscape of research Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-3667 |
0.301 |
|
| 2019 |
Patton TS, Moulder R, Alexander E, Vito D, Waller J, Gaynor C, Thomas S, Farrow B, Yamada J, Cullion K, Winchester D, Waanders A, Heath A, Raman P, Resnick A, et al. Abstract 3356: Working together to put kids first: Outreach strategies driving collaborative research, data sharing and cross-disease analysis to accelerate discoveries in pediatric cancer and structural birth defects Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-3356 |
0.352 |
|
| 2019 |
Zhu Y, Brown M, Devkota B, Farrow B, Gavrilovic B, Heath A, Hernandez K, Kelman A, Killada P, Kim MC, Kolbman D, Koptyra M, Kovacevic M, Leerkes M, Lubneuski A, ... ... Raman P, et al. Abstract 2465: Genomic harmonization of the Data Resource Center for Gabriella Miller Kids First Pediatric Research Program Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2465 |
0.564 |
|
| 2019 |
Heath AP, Taylor DM, Zhu Y, Raman P, Lilly J, Storm P, Waanders AJ, Ferretti V, Yung C, Mattioni M, Davis-Dusenbery B, Flamig ZL, Grossman R, Volchenboum SL, Mueller S, et al. Abstract 2464: Gabriella Miller Kids First Data Resource Center: Harmonizing clinical and genomic data to support childhood cancer and structural birth defect research Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2464 |
0.609 |
|
| 2019 |
Weiner AK, Radaoui AB, Kendsersky NM, Harenza-Rokita JL, Sidoli S, Conkrite KL, Vaksman Z, Rathi K, Raman P, Martinez D, Bhatti T, Tsang M, Pawel B, Garcia BA, Maris JM, et al. Abstract 3650: Integrative mass spectrometry and RNA-sequencing identifies DLK1 as a candidate immunotherapeutic target in neuroblastoma Cancer Research. 79: 3650-3650. DOI: 10.1158/1538-7445.Am2019-3650 |
0.373 |
|
| 2019 |
Weiner AK, Radaoui AB, Tsang M, Martinez D, Sidoli S, Conkrite KL, Delaidelli A, Rokita JL, Lane MV, Vaksman Z, Rathi KS, Raman P, Pogoriler J, Bhatti T, Pawel B, et al. Abstract LB-B04: A multi-omic surfaceome study identifies DLK1 as an epigenetically regulated protein and immunotherapeutic target in neuroblastoma Molecular Cancer Therapeutics. 18. DOI: 10.1158/1535-7163.Targ-19-Lb-B04 |
0.398 |
|
| 2019 |
Ijaz H, Koptyra M, Gaonkar K, Rokita JL, Baubet V, Tauhid L, Zhu Y, Brown M, Lopez G, Zhang B, Diskin S, Vaksman Z, Mason J, Appert E, Lilly J, ... ... Raman P, et al. Pdtm-16. Pediatric High Grade Glioma Resources From The Children’S Brain Tumor Tissue Consortium (Cbttc) And Pediatric Brain Tumor Atlas (Pbta) Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.792 |
0.314 |
|
| 2019 |
Zhu Y, Guo Y, Heath A, Raman P, Appert E, Mason J, Zhang B, Kalletla K, Brown M, Singh N, Farrow B, Felmeister A, Killada P, Kim MC, Lilly J, et al. Tmod-20. The Pediatric Brain Tumor Atlas: An Initiative By The Children’S Brain Tumor Tissue Consortium And Pacific Pediatric Neurooncology Consortium Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz036.257 |
0.308 |
|
| 2019 |
Heath A, Raman P, Zhu Y, Lilly J, Taylor D, Storm P, Waanders A, Ferretti V, Mattioni M, Davis-Dusenbery B, Flamig Z, Grossman R, Volchenboum S, Mueller S, Nazarian J, et al. Tmod-19. Gabriella Miller Kids First Data Resource Center: Large-Scale Harmonized Clinical And Genomic Data Platform To Support Childhood Cancer And Structural Birth Defect Research Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz036.256 |
0.607 |
|
| 2019 |
Bonner E, Kambhampati M, Gaonkar K, Mueller S, Resnick A, Raman P, Nazarian J. Hgg-24. Comprehensive Genomic Analysis Of Pediatric Gliomas Uncovers Novel Mutations In Histone-Encoding Genes Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz036.118 |
0.33 |
|
| 2019 |
Wang P, Tignor N, Gygi S, Ivey R, Paulovich A, Nescizhskii A, Thakurta SG, Whiteaker J, Kennedy J, Voytovich U, Ding L, Wang LB, Raman P, Zhu Y, Hiltke T, et al. GENE-19. DEEP PROTEOMIC SURVEY ACROSS SEVEN CHILDHOOD BRAIN TUMORS Neuro-Oncology. 21: ii85-ii85. DOI: 10.1093/Neuonc/Noz036.090 |
0.327 |
|
| 2018 |
Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehár J, Kryukov GV, Sonkin D, Reddy A, Liu M, Murray L, Berger MF, Monahan JE, ... ... Raman P, et al. Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. PMID 30559381 DOI: 10.1038/S41586-018-0722-X |
0.324 |
|
| 2018 |
Gröbner SN, Worst BC, Weischenfeldt J, Buchhalter I, Kleinheinz K, Rudneva VA, Johann PD, Balasubramanian GP, Segura-Wang M, Brabetz S, Bender S, Hutter B, Sturm D, Pfaff E, Hübschmann D, ... ... Raman P, et al. Author Correction: The landscape of genomic alterations across childhood cancers. Nature. PMID 29875405 DOI: 10.1038/S41586-018-0167-2 |
0.331 |
|
| 2018 |
Mackay A, Burford A, Molinari V, Jones DTW, Izquierdo E, Brouwer-Visser J, Giangaspero F, Haberler C, Pietsch T, Jacques TS, Figarella-Branger D, Rodriguez D, Morgan PS, Raman P, Waanders AJ, et al. Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial. Cancer Cell. 33: 829-842.e5. PMID 29763623 DOI: 10.1016/J.Ccell.2018.04.004 |
0.309 |
|
| 2018 |
Gröbner SN, Worst BC, Weischenfeldt J, Buchhalter I, Kleinheinz K, Rudneva VA, Johann PD, Balasubramanian GP, Segura-Wang M, Brabetz S, Bender S, Hutter B, Sturm D, Pfaff E, Hübschmann D, ... ... Raman P, et al. The landscape of genomic alterations across childhood cancers. Nature. PMID 29489754 DOI: 10.1038/Nature25480 |
0.391 |
|
| 2018 |
Guha M, Srinivasan S, Raman P, Jiang Y, Kaufman BA, Taylor D, Dong D, Chakrabarti R, Picard M, Carstens RP, Kijima Y, Feldman M, Avadhani NG. Aggressive triple negative breast cancers have unique molecular signature on the basis of mitochondrial genetic and functional defects. Biochimica Et Biophysica Acta. PMID 29309924 DOI: 10.1016/J.Bbadis.2018.01.002 |
0.599 |
|
| 2018 |
Gao J, Mazor T, Ciftci E, Raman P, Lukasse P, Bahceci I, Sigaras A, Abeshouse A, Bruijn Id, Gross B, Kundra R, Lisman A, Ochoa A, Sheridan R, Su J, et al. Abstract 923: The cBioPortal for Cancer Genomics: An intuitive open-source platform for exploration, analysis and visualization of cancer genomics data Cancer Research. 78: 923-923. DOI: 10.1158/1538-7445.Am2018-923 |
0.417 |
|
| 2018 |
Raman P, Rathi K, Kalletla K, Zhu Y, Zhang B, Cros A, Nazarian J, Waanders AJ, Mueller S, Storm PB, Resnick AC. TBIO-28. DISEASEXPRESS, A CANCER DATA ANALYTICS AND VISUALIZATION TOOL FOR IDENTIFYING IMMUNOTHERAPEUTIC TARGETS IN PEDIATRIC BRAIN TUMORS AND OTHER CANCERS Neuro-Oncology. 20: i186-i186. DOI: 10.1093/Neuonc/Noy059.716 |
0.395 |
|
| 2018 |
Heath AP, Raman P, Zhu Y, Lilly JV, Taylor D, Storm PB, Waanders AJ, Volchenboum S, Stein L, Ellrott K, Margolin A, Davis-Dusenbery B, Grossman R, Ferretti V, Mueller S, et al. TBIO-27. GABRIELLA MILLER KIDS FIRST DATA RESOURCE CENTER ADVANCING GENETIC RESEARCH IN CHILDHOOD CANCER AND STRUCTURAL BIRTH DEFECTS THROUGH LARGE SCALE INTEGRATED DATA-DRIVEN DISCOVERY AND CLOUD-BASED PLATFORMS FOR COLLABORATIVE ANALYSIS Neuro-Oncology. 20: i186-i186. DOI: 10.1093/Neuonc/Noy059.715 |
0.595 |
|
| 2018 |
Ijaz H, Dilley R, Koptra M, Garcia G, Zhu Y, Zhang B, Baubet V, Mason J, Resnick A, Gaonkar K, Waanders A, Raman P, Greenberg R, Cole K. HGG-33. PATIENT DERIVED CELL LINES TO STUDY ATRX AND ALT IN PEDIATRIC BRAIN TUMORS Neuro-Oncology. 20: i96-i96. DOI: 10.1093/Neuonc/Noy059.305 |
0.334 |
|
| 2017 |
Jain P, Silva A, Han HJ, Lang SS, Zhu Y, Boucher K, Smith TE, Vakil A, Diviney P, Choudhari N, Raman P, Busch CM, Delaney T, Yang X, Olow AK, et al. Overcoming resistance to single-agent therapy for oncogenic BRAF gene fusions via combinatorial targeting of MAPK and PI3K/mTOR signaling pathways. Oncotarget. 8: 84697-84713. PMID 29156677 DOI: 10.18632/Oncotarget.20949 |
0.315 |
|
| 2017 |
Campbell BB, Light N, Fabrizio D, Zatzman M, Fuligni F, de Borja R, Davidson S, Edwards M, Elvin JA, Hodel KP, Zahurancik WJ, Suo Z, Lipman T, Wimmer K, Kratz CP, ... ... Raman P, et al. Comprehensive Analysis of Hypermutation in Human Cancer. Cell. PMID 29056344 DOI: 10.1016/J.Cell.2017.09.048 |
0.379 |
|
| 2017 |
Mackay A, Burford A, Carvalho D, Izquierdo E, Fazal-Salom J, Taylor KR, Bjerke L, Clarke M, Vinci M, Nandhabalan M, Temelso S, Popov S, Molinari V, Raman P, Waanders AJ, et al. Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma. Cancer Cell. PMID 28966033 DOI: 10.1016/J.Ccell.2017.08.017 |
0.348 |
|
| 2017 |
Bosse KR, Raman P, Zhu Z, Lane M, Martinez D, Heitzeneder S, Rathi KS, Kendsersky NM, Randall M, Donovan L, Morrissy S, Sussman RT, Zhelev DV, Feng Y, Wang Y, et al. Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma. Cancer Cell. 32: 295-309.e12. PMID 28898695 DOI: 10.1016/J.Ccell.2017.08.003 |
0.367 |
|
| 2017 |
Resnick AC, Storm PB, Waanders AJ, Lilly JV, Lulla RR, Mueller S, Prados M, Sender LS, Heath A, Felmeister AS, Cros A, Zhu Y, Raman P. Abstract LB-008: The Pediatric Brain Tumor Atlas: building an integrated, multi-platform data-rich ecosystem for collaborative discovery in the cloud Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-008 |
0.335 |
|
| 2017 |
Bosse KR, Raman P, Lane M, Sussman RT, Harenza JL, Martinez D, Heitzeneder S, Zhu Z, Rathi K, Randall M, Donovan L, Morrissy S, Zhelev DV, Feng Y, Hwang J, et al. Abstract 685: GPC2 is an oncogene and immunotherapeutic target in high-risk neuroblastoma Cancer Research. 77: 685-685. DOI: 10.1158/1538-7445.Am2017-685 |
0.413 |
|
| 2017 |
Harenza JL, Diamond MA, Oldridge DA, Padovan-Merher O, Raman P, Mosse YP, Maris JM. Abstract 3000: Defining the subclonal landscape of high-risk neuroblastoma Cancer Research. 77: 3000-3000. DOI: 10.1158/1538-7445.Am2017-3000 |
0.37 |
|
| 2017 |
Gao J, Ciftci E, Raman P, Lukasse P, Bahceci I, Abeshouse A, Chen H, Bruijn Id, Gross B, Heins Z, Kundra R, Lisman A, Ochoa A, Sheridan R, Sumer O, et al. Abstract 2607: The cBioPortal for Cancer Genomics: an open source platform for accessing and interpreting complex cancer genomics data in the era of precision medicine Cancer Research. 77: 2607-2607. DOI: 10.1158/1538-7445.Am2017-2607 |
0.415 |
|
| 2017 |
Raman P, Waanders AJ, Storm PB, Lilly JV, Mason J, Heath AP, Felmeister AS, Cros A, Zhu Y, Sender L, Prados M, Mueller S, Lulla R, Nazarian J, Resnick AC. Gene-15. Cavatica- A Pediatric Genomic Cloud Empowering Data Discovery Through The Pediatric Brain Tumor Atlas Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox083.086 |
0.382 |
|
| 2017 |
Felmeister A, Lulla R, Waanders A, Raman P, Santi M, Lilly J, Mason J, Nazarian J, Resnick A. Gene-12. The Children’S Brain Tumor Tissue Consortium (Cbttc) Infrastructure Facilitates Collaborative Research In Pediatric Central Nervous System Tumors Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox083.083 |
0.344 |
|
| 2016 |
Padovan-Merhar OM, Raman P, Ostrovnaya I, Kalletla K, Rubnitz KR, Sanford EM, Ali SM, Miller VA, Mossé YP, Granger MP, Weiss B, Maris JM, Modak S. Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome. Plos Genetics. 12: e1006501. PMID 27997549 DOI: 10.1371/Journal.Pgen.1006501 |
0.371 |
|
| 2016 |
Tarangelo A, Lo N, Teng R, Kim E, Raman P, Viatour P. Abstract PR07: Recruitment of Pontin/Reptin by E2F1 amplifies E2F transcriptional response during cancer progression Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Cellcycle16-Pr07 |
0.394 |
|
| 2016 |
Bosse KR, Raman P, Sussman RT, Randall M, Martinez D, Zhu Z, Pawel B, Bhatti T, Khan J, Dimitrov DS, Mackall C, Maris JM. Abstract PR02: GPC2 is a candidate immunotherapeutic target and putative oncogene in high-risk neuroblastoma and other pediatric cancers Cancer Research. 76. DOI: 10.1158/1538-7445.Pedca15-Pr02 |
0.447 |
|
| 2016 |
Hart LS, Raman P, Coggins G, Rader J, Maris JM. Abstract LB-126: The identification of synthetic lethal partners cooperating with MEK1/2 inhibition in neuroblastoma Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-126 |
0.379 |
|
| 2016 |
Padovan-Merhar OM, Raman P, Rubnitz KR, Ali SM, Miller VA, Mosse YP, Granger MP, Weiss BD, Maris JM, Modak S. Abstract 2431: Enrichment of targetable mutations in the relapsed neuroblastoma genome Cancer Research. 76: 2431-2431. DOI: 10.1158/1538-7445.Am2016-2431 |
0.314 |
|
| 2016 |
Raman P, Resnick AC, Storm PB, Mueller S, Schultz N, Cerami E, Maris JM, Waanders AJ. GENT-31. PEDcBIOPORTAL: A CANCER DATA VISUALIZATION TOOL FOR INTEGRATIVE PEDIATRIC CANCER ANALYSES Neuro-Oncology. 18: vi80-vi80. DOI: 10.1093/Neuonc/Now212.337 |
0.346 |
|
| 2015 |
Raman P, Purwin T, Pestell R, Tozeren A. FXYD5 is a Marker for Poor Prognosis and a Potential Driver for Metastasis in Ovarian Carcinomas. Cancer Informatics. 14: 113-9. PMID 26494976 DOI: 10.4137/Cin.S30565 |
0.383 |
|
| 2015 |
Schnepp RW, Khurana P, Attiyeh EF, Raman P, Chodosh SE, Oldridge DA, Gagliardi ME, Conkrite KL, Asgharzadeh S, Seeger RC, Madison BB, Rustgi AK, Maris JM, Diskin SJ. A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis. Cancer Cell. 28: 599-609. PMID 26481147 DOI: 10.1016/J.Ccell.2015.09.012 |
0.302 |
|
| 2015 |
Russell MR, Penikis A, Oldridge DA, Alvarez-Dominguez JR, McDaniel L, Diamond M, Padovan O, Raman P, Li Y, Wei JS, Zhang S, Gnanchandran J, Seeger R, Asgharzadeh S, Khan J, et al. CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus. Cancer Research. PMID 26100672 DOI: 10.1158/0008-5472.Can-14-3613 |
0.364 |
|
| 2015 |
Carson C, Raman P, Tullai J, Xu L, Henault M, Thomas E, Yeola S, Lao J, McPate M, Verkuyl JM, Marsh G, Sarber J, Amaral A, Bailey S, Lubicka D, et al. Englerin A Agonizes the TRPC4/C5 Cation Channels to Inhibit Tumor Cell Line Proliferation. Plos One. 10: e0127498. PMID 26098886 DOI: 10.1371/Journal.Pone.0127498 |
0.324 |
|
| 2015 |
Healy JR, Schnepp RW, Hart LS, Raman P, Danielson L, Russell M, Khurana P, Gagliardi M, Kinsey RM, Wyce A, Barbash O, Tummino PJ, Chesler L, Maris JM. Abstract B34: Antitumor activity and sensitivity evaluation of novel BET inhibitors in neuroblastoma Molecular Cancer Research. 13. DOI: 10.1158/1557-3125.Myc15-B34 |
0.407 |
|
| 2015 |
Schnepp RW, Khurana P, Attiyeh EF, Chodosh S, Raman P, Oldridge DA, Gagliardi ME, Conkrite K, Asgharzadeh S, Seeger RC, Madison B, Rustgi A, Maris JM, Diskin SJ. Abstract 4734: A LIN28B/RAN/AURKA signaling network promotes neuroblastoma tumorigenesis Cancer Research. 75: 4734-4734. DOI: 10.1158/1538-7445.Am2015-4734 |
0.399 |
|
| 2015 |
Rader J, Raman P, Hart L, Russell M, Cole KA, Maris JM. Abstract 4305: NMI as a biomarker of response to CDK4/6 inhibition in a preclinical model of neuroblastoma Cancer Research. 75: 4305-4305. DOI: 10.1158/1538-7445.Am2015-4305 |
0.361 |
|
| 2015 |
Hart LS, Chen L, Batra V, Tsang M, Raman P, Caponigro G, Krupa S, Boehm M, Peters M, Maris JM. Abstract 3494: Combined MEK1/2 and PI3K inhibition induces synergistic caspase-dependent apoptosis in neuroblastoma Cancer Research. 75: 3494-3494. DOI: 10.1158/1538-7445.Am2015-3494 |
0.364 |
|
| 2015 |
Sussman RT, Huang K, Raman P, Maris JM. Abstract 1712: CAMKV as an immunotherapy target in MYCN-amplified neuroblastoma Cancer Research. 75: 1712-1712. DOI: 10.1158/1538-7445.Am2015-1712 |
0.441 |
|
| 2015 |
Russell MR, Penikis A, Oldridge D, Alvarez-Dominguez JR, McDaniel L, Diamond M, Padovan O, Raman P, Li Y, Wei J, Zhang S, Gnanachandran J, Seeger R, Asgharzadeh S, Khan J, et al. Abstract 144: CASC15 is a tumor suppressor lncRNA at the 6p22 neuroblastoma susceptibility locus Cancer Research. 75: 144-144. DOI: 10.1158/1538-7445.Am2015-144 |
0.388 |
|
| 2014 |
Hart LS, Batra V, Raman P, Gagliardi M, Rader J, Chen L, Fritsch C, Caponigro G, Peters M, Boehm M, Maris JM. Abstract B82: MEK 1/2 inhibition and biomarkers of response in preclinical models of neuroblastoma Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-B82 |
0.386 |
|
| 2014 |
Schnepp R, Hart L, Raman P, Danielson L, Gagliardi M, Kinsey R, Wyce A, Barbash O, Tummino P, Chesler L, Maris J. Abstract B75: Defining the antitumor activity and sensitivity profiles of BET inhibitors in neuroblastoma Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-B75 |
0.403 |
|
| 2013 |
Britschgi A, Bill A, Brinkhaus H, Rothwell C, Clay I, Duss S, Rebhan M, Raman P, Guy CT, Wetzel K, George E, Popa MO, Lilley S, Choudhury H, Gosling M, et al. Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling. Proceedings of the National Academy of Sciences of the United States of America. 110: E1026-34. PMID 23431153 DOI: 10.1073/Pnas.1217072110 |
0.38 |
|
| 2013 |
Britschgi A, Bill A, Brinkhaus H, Rothwell C, Clay I, Duss S, Rebhan M, Raman P, Guy C, Wetzel K, George E, Popa MO, Lilley S, Choudhury H, Gosling M, et al. Abstract LB-205: The calcium activated chloride channel ANO1 promotes breast cancer progression by activating EGFR- and CAMK-signaling. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-205 |
0.408 |
|
| 2012 |
Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehár J, Kryukov GV, Sonkin D, Reddy A, Liu M, Murray L, Berger MF, Monahan JE, ... ... Raman P, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 483: 603-7. PMID 22460905 DOI: 10.1038/Nature11003 |
0.424 |
|
| 2011 |
Barretina J, Stransky N, Caponigro G, Kim S, Margolin A, Venkhatesan K, Kryukov G, Berger M, Monahan J, Morais P, Meltzer J, Mahan S, Sonkin D, Raman P, Jones M, et al. Abstract 5455: Integrative analysis of the Cancer Cell Line Encyclopedia reveals genetic and transcriptional predictors of compound sensitivity Cancer Research. 71: 5455-5455. DOI: 10.1158/1538-7445.Am2011-5455 |
0.434 |
|
| 2010 |
Düvel K, Yecies JL, Menon S, Raman P, Lipovsky AI, Souza AL, Triantafellow E, Ma Q, Gorski R, Cleaver S, Vander Heiden MG, MacKeigan JP, Finan PM, Clish CB, Murphy LO, et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Molecular Cell. 39: 171-83. PMID 20670887 DOI: 10.1016/J.Molcel.2010.06.022 |
0.33 |
|
| 2010 |
Venkatesan K, Stransky N, Margolin A, Reddy A, Raman P, Sonkin D, Jones M, Wilson C, Kim S, Warmuth M, Sellers W, Lehar J, Barretina J, Caponigro G, Garraway L, et al. Prediction of drug response using genomic signatures from the Cancer Cell Line Encyclopedia Clinical Cancer Research. 16. DOI: 10.1158/Diag-10-Pr2 |
0.401 |
|
| 2010 |
Barretina J, Caponigro G, Kim S, Stransky N, Venkhatesan K, Reddy V, Berger M, Morrissey M, Morais P, Meltzer J, Thibault J, Mahan S, Sonkin D, Che J, Raman P, et al. Abstract 2620: The Cancer Cell Line Encyclopedia project: From integrative cancer genomics to personalized cancer therapy Cancer Research. 70: 2620-2620. DOI: 10.1158/1538-7445.Am10-2620 |
0.463 |
|
| 2010 |
Stransky N, Venkhatesan K, Morrissey M, Barretina J, Raman P, Getz G, Berger M, Johannessen C, Callahan A, Morais P, Mahan S, Gupta S, Onofrio R, Sougnez C, Winckler W, et al. Abstract 105: Integrative analysis of genomic and pharmacologic data from the Cancer Cell Line Encyclopedia Cancer Research. 70: 105-105. DOI: 10.1158/1538-7445.Am10-105 |
0.472 |
|
| 2010 |
Stransky N, Venkatesan K, Barretina J, Caponigro G, Margolin A, Morrissey M, Raman P, Getz G, Berger M, Johannessen C, Callahan A, Morais P, Mahan S, Gupta S, Onofrio R, et al. Abstract PR4: Integrative analysis of genomic and pharmacologic data from the Cancer Cell Line Encyclopedia Clinical Cancer Research. 16. DOI: 10.1158/1078-0432.Tcmusa10-Pr4 |
0.437 |
|
| Show low-probability matches. |